Does WARFARIN Cause Malignant neoplasm progression? 34 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Malignant neoplasm progression have been filed in association with WARFARIN (Warfarin Sodium). This represents 0.1% of all adverse event reports for WARFARIN.
34
Reports of Malignant neoplasm progression with WARFARIN
0.1%
of all WARFARIN reports
17
Deaths
22
Hospitalizations
How Dangerous Is Malignant neoplasm progression From WARFARIN?
Of the 34 reports, 17 (50.0%) resulted in death, 22 (64.7%) required hospitalization, and 2 (5.9%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for WARFARIN. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does WARFARIN Cause?
International normalised ratio increased (5,622)
Haemorrhage (2,930)
Gastrointestinal haemorrhage (2,469)
Anaemia (2,409)
Drug interaction (2,056)
Fall (1,702)
Drug ineffective (1,658)
Epistaxis (1,498)
Contusion (1,467)
Dyspnoea (1,374)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)